Nutritional status and follicular-derived thyroid cancer: An update L Barrea, M Gallo, RM Ruggeri, PD Giacinto, F Sesti, N Prinzi, V Adinolfi, ... Critical reviews in food science and nutrition 61 (1), 25-59, 2021 | 87 | 2021 |
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors< 2 centimeters A Faggiano, R Modica, F Lo Calzo, L Camera, V Napolitano, B Altieri, ... The Journal of Clinical Endocrinology & Metabolism 105 (1), 78-84, 2020 | 47 | 2020 |
One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden TV Fiorentino, F Sesti, F Andreozzi, E Pedace, A Sciacqua, ML Hribal, ... Atherosclerosis 253, 61-69, 2016 | 44 | 2016 |
Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals TV Fiorentino, F Sesti, E Succurro, E Pedace, F Andreozzi, A Sciacqua, ... Acta diabetologica 55, 835-842, 2018 | 39 | 2018 |
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study T Feola, G Puliani, F Sesti, R Modica, R Centello, R Minotta, G Cannavale, ... Journal of Endocrinological Investigation 45 (4), 849-857, 2022 | 36 | 2022 |
Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial R Pofi, E Giannetta, T Feola, N Galea, F Barbagallo, F Campolo, ... Science Translational Medicine 14 (649), eabl8503, 2022 | 25 | 2022 |
Advances in the management of medullary thyroid carcinoma: focus on peptide receptor radionuclide therapy E Grossrubatscher, G Fanciulli, L Pes, F Sesti, C Dolci, F de Cicco, ... Journal of Clinical Medicine 9 (11), 3507, 2020 | 25 | 2020 |
NETest: a systematic review focusing on the prognostic and predictive role G Puliani, V Di Vito, T Feola, F Sesti, R Centello, C Pandozzi, ... Neuroendocrinology 112 (6), 523-536, 2022 | 23 | 2022 |
Testicular ultrasound score: a new proposal for a scoring system to predict testicular function C Pozza, G Kanakis, F Carlomagno, A Lemma, R Pofi, M Tenuta, ... Andrology 8 (5), 1051-1063, 2020 | 23 | 2020 |
Late‐onset hypogonadism: Reductio ad absurdum of the cardiovascular risk‐benefit of testosterone replacement therapy F Sesti, R Pofi, M Minnetti, M Tenuta, D Gianfrilli, AM Isidori Andrology 8 (6), 1614-1627, 2020 | 22 | 2020 |
Expected and paradoxical effects of obesity on cancer treatment response M Gallo, V Adinolfi, V Barucca, N Prinzi, V Renzelli, L Barrea, ... Reviews in Endocrine and Metabolic Disorders, 1-22, 2020 | 21 | 2020 |
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? G Vitale, A Dicitore, L Barrea, E Sbardella, P Razzore, S Campione, ... Reviews in Endocrine and Metabolic Disorders 22 (3), 511-525, 2021 | 20 | 2021 |
A novel MAX gene mutation variant in a patient with multiple and “composite” neuroendocrine–neuroblastic tumors C Pozza, F Sesti, C Di Dato, E Sbardella, R Pofi, F Schiavi, V Bonifacio, ... Frontiers in endocrinology 11, 234, 2020 | 19 | 2020 |
Neuroendocrine carcinomas with atypical proliferation index and clinical behavior: a systematic review T Feola, R Centello, F Sesti, G Puliani, M Verrico, V Di Vito, C Di Gioia, ... Cancers 13 (6), 1247, 2021 | 18 | 2021 |
Use of contrast enhanced ultrasound in testicular diseases: A comprehensive review M Tenuta, F Sesti, I Bonaventura, P Mazzotta, R Pofi, D Gianfrilli, C Pozza Andrology 9 (5), 1369-1382, 2021 | 16 | 2021 |
Laryngeal neuroendocrine tumor with elevated serum calcitonin: a diagnostic and therapeutic challenge. Case report and review of literature T Feola, G Puliani, F Sesti, R Modica, M Biffoni, C Di Gioia, R Carletti, ... Frontiers in Endocrinology 11, 397, 2020 | 15 | 2020 |
Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study TV Fiorentino, E Succurro, F Arturi, A Giancotti, C Peronace, A Quirino, ... Scientific reports 8 (1), 13616, 2018 | 13 | 2018 |
Frequency of 1-h post-load glucose≥ 155 mg/dl among individuals with different glucose tolerance conditions TV Fiorentino, F Sesti, F Andreozzi, E Pedace, E Succurro, A Sciacqua, ... Nutrition, Metabolism and Cardiovascular Diseases 26 (5), 439-441, 2016 | 13 | 2016 |
Somatostatin analogue therapy in MEN1-related pancreatic neuroendocrine tumors from evidence to clinical practice: A systematic review A La Salvia, F Sesti, C Grinzato, R Mazzilli, MG Tarsitano, E Giannetta, ... Pharmaceuticals 14 (10), 1039, 2021 | 11 | 2021 |
Prognostic significance of laterality in lung neuroendocrine tumors A La Salvia, I Persano, A Siciliani, M Verrico, M Bassi, R Modica, ... Endocrine 76 (3), 733-746, 2022 | 10 | 2022 |